Abstract
This meeting showed how the surge of research in the field of NO biology has led to novel therapeutic approaches in multiple clinical disciplines. Some approaches have already advanced towards clinical applications. Continued research efforts will undoubtedly lead to new applications.
MeSH terms
-
Animals
-
Arteriosclerosis / drug therapy
-
Arteriosclerosis / physiopathology
-
Clinical Trials, Phase I as Topic
-
Enzyme Inhibitors / pharmacology
-
Enzyme Inhibitors / therapeutic use
-
Humans
-
Hypertension, Pulmonary / drug therapy
-
Inflammation / drug therapy
-
Inflammation / physiopathology
-
Nitric Oxide / metabolism*
-
Nitric Oxide / pharmacology
-
Nitric Oxide Synthase / antagonists & inhibitors
-
Nitric Oxide Synthase / metabolism
-
Shock, Septic / drug therapy
-
Shock, Septic / physiopathology
-
omega-N-Methylarginine / pharmacology
-
omega-N-Methylarginine / therapeutic use
Substances
-
Enzyme Inhibitors
-
omega-N-Methylarginine
-
Nitric Oxide
-
Nitric Oxide Synthase